- Home
- PLX vs KINS Comparison
PLX vs KINS Comparison
Compare PLX & KINS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PLX
- KINS
- Stock Information
- Founded
- PLX 1993
- KINS 1886
- Country
- PLX United States
- KINS United States
- Employees
- PLX N/A
- KINS N/A
- Industry
- PLX Biotechnology: Biological Products (No Diagnostic Substances)
- KINS Property-Casualty Insurers
- Sector
- PLX Health Care
- KINS Finance
- Exchange
- PLX Nasdaq
- KINS Nasdaq
- Market Cap
- PLX 204.9M
- KINS 189.6M
- IPO Year
- PLX 1998
- KINS N/A
- Fundamental
- Price
- PLX $1.85
- KINS $14.47
- Analyst Decision
- PLX Strong Buy
- KINS
- Analyst Count
- PLX 1
- KINS 0
- Target Price
- PLX $15.00
- KINS N/A
- AVG Volume (30 Days)
- PLX 1.1M
- KINS 134.5K
- Earning Date
- PLX 11-13-2025
- KINS 11-06-2025
- Dividend Yield
- PLX N/A
- KINS 1.38%
- EPS Growth
- PLX N/A
- KINS 325.10
- EPS
- PLX 0.08
- KINS 2.04
- Revenue
- PLX $61,948,000.00
- KINS $183,702,376.00
- Revenue This Year
- PLX $14.53
- KINS $41.35
- Revenue Next Year
- PLX $75.77
- KINS $12.33
- P/E Ratio
- PLX $24.02
- KINS $7.09
- Revenue Growth
- PLX 62.79
- KINS 28.36
- 52 Week Low
- PLX $1.01
- KINS $9.50
- 52 Week High
- PLX $3.10
- KINS $22.40
- Technical
- Relative Strength Index (RSI)
- PLX 38.39
- KINS 49.00
- Support Level
- PLX $2.31
- KINS $14.23
- Resistance Level
- PLX $2.55
- KINS $15.19
- Average True Range (ATR)
- PLX 0.15
- KINS 0.51
- MACD
- PLX -0.06
- KINS 0.00
- Stochastic Oscillator
- PLX 23.70
- KINS 19.80
About PLX Protalix BioTherapeutics Inc. (DE)
Protalix BioTherapeutics Inc is a biopharmaceutical company focused on the development and commercialization of recombinant therapeutic proteins based on its proprietary ProCellEx protein expression system or ProCellEx. It has developed taliglucerase alfa for the treatment of Gaucher disease. The company's products also treat diseases like Fabry disease and cystic fibrosis. The company's primary sources of revenue include its sales of BioManguinhos alfataliglicerase in Brazil and of drug substances to Pfizer under its Amended Pfizer Agreement. The company's pipeline consists of ELFABRIO, Uricase, and Long Acting DNase I.
About KINS Kingstone Companies Inc.
Kingstone Companies Inc is a multi-line regional property and casualty insurance holding company. It offers insurance policies to small and mid-sized businesses as well as to individuals.